Lostam BioPharmaceuticals Overview
- Founded
- 2009
- Status
- Out of Business
- Latest Deal Type
- Out of Business
Lostam BioPharmaceuticals General Information
Description
Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.
Contact Information
Website
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
- Nazareth Industrial Area
- PO Box 2252
- Nazareth 16000
- Israel
Lostam BioPharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Jul-2017 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | Completed | Startup |
Lostam BioPharmaceuticals Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Lewis Neville Ph.D | Founder, Chief Technology Officer & Chief Executive Officer |